Role of ayurveda in tumorigenesis: A brief review

Tejal Sharma, Gaurav Rawal

Abstract


From ancient times, many herbal compounds have been screened worldwide to validate their use as anticancer drugs. But an
integrated approach is required along with complete knowledge about the disease. Hence, an attempt has been made in this review
to discuss about the role of Ayurveda in cancer therapy. Also, discussion about the pathology and therapeutic management of
various cancers described in Ayurveda has been made in this review. Review of literature on anticancer drugs of plant origin revealed
identification of newer several Ayurvedic drugs that can be used for the treatment of one of the most dreaded diseases, i.e. cancer.
Key words: Ayurveda, cancer, integrated, therapy

Full Text:

PDF

References


Aggarwal BB, Ichiwaka H, Garodia P, Weerasinghe P, Sethi G,

Bhatt ID, et al. From traditional Ayurvedic medicine to another

medicine: Identification of therapeutic targets for suppression

of inflammation and cancer. Expert Opin Their Targets 2006;

:87‑118.

Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB,

Tharakan ST, Lai OS, et al. Cancer is a preventable disease that

requires major lifestyle changes. Pharm Res 2008;25:2097‑116.

Hartwell JL. Plants used against cancer. A survey. Lloydia

;32:247‑96.

Hartwell JL. Plants used against cancer. A survey. Lloydia

;32:153‑205.

Hartwell JL. Plants used against cancer. A survey. Lloydia

;32:78‑107.

Hartwell JL. Plants used against cancer. A survey. Lloydia

;33:288‑392.

Hartwell JL. Plants used against cancer. A survey. Lloydia

;33:97‑194.

Hartwell JL. Plants used against cancer. A survey. Lloydia

;34:386‑425.

Hartwell JL. Plants used against cancer. A survey. Lloydia

;34:204‑55.

Hartwell JL. Plants used against cancer. A survey. Lloydia

;34:310‑61.

Hartwell JL. Plants used against cancer. A survey. Lloydia

;34:103‑50.

Pandey G. Anticancer herbal drugs of India with special reference

to Ayurveda. New Delhi: Sri Satguru Publications; 2002. p. 18‑121.

Avaialble from: http://herb4cancer.wordpress.com/2007/11/28/

herbal‑medicine‑for‑cancer‑treatment/29/. [Last accessed on

Dec 28].

CHARAKA: Charaka Samhita. Varanasi, India: Chaukhamba

Orientalia; 700 BC.

SUSRUTA: Susruta Samhita. Varanasi, India: Chaukhamba

Surbharati Publications; 700 BC.

MISRA B: Bhawa Prakash Nighantu. Varanasi, India: Chaukhamba

Publications; 1600 AD.

KAPOOR LD: Handbook of ayurvedic medicinal plants. Florida:

CRC Press; 1990.

Balachandran P, Govindarajan R. Cancer‑an ayurvedic perspective.

Pharmacol Res 2005;51:19‑30.

Singh RH. An assessment of the ayurvedic concept of cancer and

a new paradigm of anticancer treatment in Ayurveda. J Altern

Complement Med 2002;8:609‑14.

Smit HF, Woerdenbag HJ, Singh RH, Meulenbeld GJ, Labadie RP,

Zwaving JH. Ayurvedic herbal drugs with possible cytostatic

activity. J Ethnopharmacol 1995;47:75‑84.

Sastry JL. Introduction to oncology, cancer in Ayurveda. Varanasi:

Chaukhambha orientalia; 2001.p. 1‑24.

Prasad GC. Studies on cancer in Ayurveda and its management.

Journal of Research in Ayurveda and Siddha1987;3:147‑67.

Sharma PV. Charaka Samhita. Varanasi: Choukhamba Orientalia;

Bhishagratha KL. Sushruta samhita. Varanasi: Choukhamba

Orientalia; 1991.

Ranbaxy Science Foundation: Round Table Conference Series

Herbal Drugs‑ Perspectives in the new millennium. 2006.

Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties

of six rasayana herbs used in ayurvedic medicine. Phytother Res

;13:275‑91.

Jang M, Cai L, Udeani GO, Beecher CW, Fong HH, Farnsworth NR,

et al. Cancer chemopreventive activity of Resveratrol, a natural

product derived from Grapes. Science 1997;275:218‑20.

Murthy KR. Bhavaprakasa of bhavamisra. Vol. II. Madhya and

Uttara Khanda. Varanasi: Krishnadas Academy; 2001.

Trivedi N, Rawal UM. Effect of aqueous extract of Andrographis

paniculata on liver tumour. Indian J Pharmacol 1998;30:318‑22.

Trivedi NP, Rawal UM. Hepatoprotective and antioxidant property

of Andrographis paniculata in BHC induced liver damage in mice.

Indian J Exp Biol 2001;39:41‑6.

Singh RP, Bannerjee S, Rao AR. Modulatory influence of

Andrographis paniculata on mouse hepatic and extrahepatic

carcinogen metabolizing enzymes and antioxidant status.

Phytother Res 2001;15:382‑90.

Kapil A. Antihepatoxic effects of major diterpenoid constituents

of Andrographis paniculata. Biochem Pharmacol 1993;46:182‑5.

Urizar NL, Moore DD. GUGULIPID: A natural cholesterol

lowering agent. Annu Rev Nutr 2003;23:303‑13.

Sinal CJ, Gonzalez FJ. Guggulsterone: An old approach to a new

problem. Trends Endocrinol Metab 2002;13:275‑6.

Gujral ML, Sareen K, Tangri KK, Amma MK, Roy AK. Antiarthritic

and anti‑inflammatory activity of gum guggul (Balsamodendron

mukul Hook). Indian J Physiol Pharmacol 1960;4:267‑73.

Sharma JN. Comparison of the anti‑inflammatory activity

of Commiphora mukul (an indigenous drug) with those of

phenylbutazone and ibuprofen in experimental arthritis induced

by mycobacterial adjuvant. Arzneimittelforschung 1977;27:1455‑7.

Singh BB, Mishra LC, Vinjamury SP, Aquilina N, Singh VJ,

Shepard N. The effectiveness of Commiphora mukul for

osteoarthritis of the knee: An outcomes study. Altern Ther Health

Med 2003;9:74‑9.

Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y,

et al. A natural product that lowers cholesterol as an antagonist

ligand for FXR. Science 2002;296:1703‑6.

Wu J, Xia C, Meier J, Li S, Hu X, Lala DS. The hypolipidemic

natural product guggulsterone acts as an antagonist of the bile

acid receptor. Mol Endocrinol 2002;16:1590‑7.

Cui J, Huang L, Zhao A, Lew JL, Yu J, Sahoo S, et al. Guggulsterone

is a farnesoid X receptor antagonist in coactivator association

assays but acts to enhance transcription of bile salt export pump.

J Biol Chem 2003;278:10214‑20.

Meselhy MR. Inhibition of LPS‑induced NO production by the

oleogum resin of Commiphora wightii and its constituents.

Phytochemistry 2003;62:213‑8.

Rajeshkumar NV, Kuttan R. Phyllanthus amarus extract

administration increases the life span of rats with hepatocellular

carcinoma. J Ethnopharmacol 2000;73:215‑9.

Lee CD, Ott M, Thyagarajan SP, Shafritz DA, Burk RD, Gupta S.

Phyllanthus amarus down‑regulates hepatitis B virus mRNA

transcription and replication. Eur J Clin Invest 1996;26:1069‑76.

Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane)

inhibits constitutive and IL‑6‑inducible STAT3 phosphorylation in

human multiple myeloma cells. J. Immunol 2003;171:3863‑71.

Anto RJ, Mokhopadhyay A, Denning K, Aggarwal BB. Curcumin

(diferuloylmethane) induces apoptosis through activation of

caspase‑8, BID cleavage and cytochrome c release: Its suppression

by ectopic expression of Bcl‑2 and Bcl‑xl. Carcinogenesis

;23:143‑50.

Mukhopadhyay A, Bueso‑Ramos C, Chatterjee D, Pantazis P,

Aggarwal BB. Curcumin downregulates cell survival mechanisms

in human prostate cancer cell lines. Oncogene 2001;20:7597‑609.

Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M,

Aggarwal BB. Curcumin‑induced suppression of cell proliferation

correlates with down‑regulation of cyclin D1 expression and

CDK4‑mediated retinoblastoma protein phosphorylation.

Oncogene 2002;21:8852‑61.

Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of

curcumin: Preclinical and clinical studies. Anticancer Res

;23:363‑98.

Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin

(diferuloylmethane) downregulates cigarette smoke‑induced

NFkappaB activation through inhibition of IkappaBalpha kinase

in human lung epithelial cells: Correlation with suppression of

COX‑2, MMP‑9 and cyclin D1. Carcinogenesis 2003;24:1269‑79.

Bharti AC, Takada Y, Aggarwal B. Curcumin (diferuloylmethane)

inhibits receptor activator of NF‑kappaB ligand‑induced

NF‑kappaB activation in osteoclast precursors and suppresses

osteoclastogenesis. J Immunol 2004;172:5940‑7.

Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R,

Raj‑Vadhan S, et al. Nuclear factor‑kappaB and STAT3 are

constitutively active in CD138+ cells derived from multiple

myeloma patients, and suppression of these transcription factors

leads to apoptosis. Blood 2004;103:3175‑84.

Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin

(diferuloylmethane) down‑regulates the constitutive activation

of nuclear factorkappa B and IkappaBalpha kinase in human

multiple myeloma cells, leading to suppression of proliferation

and induction of apoptosis. Blood 2003;101:1053‑62.

Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition

of growth and survival of human head and neck squamous

cell carcinoma cells by curcumin via modulation of nuclear

factor‑kappaB signaling. Int J Cancer 2004;111:679‑92.

Aggarwal BB, Takada Y, Oommen OV. From chemoprevention to

chemotherapy: Common targets and common goals. Expert Opin

Investig Drugs 2004;13:1327‑38.

Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R.

Nuclear factor‑kappaB and IkappaB kinase are constitutively

active in human pancreatic cells, and their down‑regulation by

curcumin (diferuloylmethane) is associated with the suppression

of proliferation and the induction of apoptosis. Cancer

;101:2351‑62.

Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer

therapy. Cancer Lett 2004;215:129‑40.

Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Nonsteroidal

antiinflammatory agents differ in their ability to suppress

NF‑kappaB activation, inhibition of expression of cyclooxygenase‑2

and cyclin D1, and abrogation of tumor cell proliferation.

Oncogene 2004;23:9247‑58.

Aggarwal BB, Shishodia S. Suppression of the nuclear factor‑kappaB

activation pathway by spice‑derived phytochemicals: Reasoning

for seasoning. Ann N Y Acad Sci 2004;1030:434‑41.

Bharti AC, Takada Y, Aggarwal BB. PARP cleavage and caspase

activity to assess chemosensitivity. Methods Mol Med 2005;111:69‑78.

Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R. Curcumininduced

antiproliferative and proapoptotic effects in melanoma

cells are associated with suppression of IkappaB kinase and

nuclear factor kappaB activity and are independent of the B‑Raf/

mitogenactivated/extracellular signal‑regulated protein kinase

pathway and the Akt pathway. Cancer 2005;104:879‑90.

Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin

(diferuloylmethane) inhibits constitutive NF‑kappaB activation,

induces G1/S arrest, suppresses proliferation, and induces

apoptosis in mantle cell lymphoma. Biochem Pharmacol

;70:700‑13.

Yan C, Jamaluddin MS, Aggarwal B, Myers J, Boyd DD. Gene

expression profiling identifies activating transcription factor 3 as

a novel contributor to the proapoptotic effect of curcumin. Mol

Cancer Ther 2005;4:233‑41.

Shishodia S, Gethi G, Aggarwal BB. Curcumin: Getting back to

the roots. Ann N Y Acad Sci 2005;1056:206‑17.

Aggarwal BB, Kumar A, Bharti AC. Therapeutic potential of

curcumin derived from turmeric (Curcuma longa). New York:

Marcel Dekker; 2004.

Aggarwal BB, Kumar S, Aggarwal S, Shishodia S. Curcumin

derived from turmeric (Curcuma longa): A spice for all seasons.

In: Bagchi D, Preuss HG, editors. Phytochemicals in Cancer

Chemoprevention. 2005.

Koul IB, Kapil A. Evaluation of the liver protective potential of

piperine. Planta Med 1993;59:413‑7.

Cavalli F, Tschopp L, Gerber A, Sonntag RW, Ryssel HJ,

Brunner KW. Therapiersultate mit VP 16.213 allein oder kombiniert

mit 5‑ fluorouracil beim leberzell karzinom (hepatoma). Vol 107.

Schweiz: Med Wochenschr; 1977. p. 1960‑6.

Pallavacini EB, Porta C, Moroni M, Moroni M, Bertulezzi G,

Civelli L, et al. Epirubicin and etoposide combination chemotherapy

to treat hepatocellular carcinoma patients: A phase II study. Eur J

Cancer 1997;33:1784‑8.

Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary

hepatocellular carcinoma: Current status and future directions.

Cancer Treat Rev 1988;15:1‑31.

Park JG, Lee SH, Hong IG, Kim HS, Lim KH, Choe KJ, et al.

MDR1 gene expression its effect on drug resistance to doxorubicin

in human hepatocellular carcinoma cell lines. J Natl Cancer Inst

;86:700‑5.

Aita P, Robieux I, Sorio R, Tumolo S, Corona G, Cannizzaro R, et al.

Pharmacokinetics of oral etoposide in patients with hepatocellular

carcinoma. Cancer Chemother Pharmacol 1999;43:287‑94.

Kirtikar KR, Basu BD. Indian Medicinal Plants. Allahabad:

Published by Lalit Mohan Basu;1935.

Hager’s handbuch der Pharmazeut, Praxis. Berlin: Springer‑Verlag;

The Wealth of India; Raw Materials. Delhi: CSIR Publications; 1948.

Reddy GK, Chandrakasan G, Dhar SC. Studies on the metabolism

of glycosaminoglycans under the influence of new herbal

anti‑inflammatory agents. Biochem Pharmacol 1989;38:3527‑34.

Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR,

Ammon HP. Boswellic acids: Novel, specific, nonredox inhibitors

of 5‑lipoxygenase. J Pharmacol Exp Ther 1992;261:1143‑6.

Safayhi H, Sailer ER, Ammon HP. Mechanism of 5‑lipoxygenase

inhibition by acetyl‑11‑keto‑beta‑boswellic acid. Mol Pharmacol

;47:1212‑6.

Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of

antiinflammatory actions of curcumine and boswellic acids.

J Ethnopharmacol 1993;38:113‑9.

Kapil A, Moza N. Anticomplementary activity of boswellic

acids‑an inhibitor of C3‑convertase of the classical complement

pathway. Int J Immunopharmacol 1992;14:1139‑43.

Safayhi H, Rall B, Sailer ER, Ammon HP. Inhibition by boswellic

acids of human leukocyte elastase. J Pharmacol Exp Ther

;281:460‑3.

Sohini YR, Bhatt RM. Activity of a crude extract formulation in

experimental hepatic amoebiasis and in immunomodulation

studies. J Ethnopharmacol 1996;54:119‑24.

Kapil A, Sharma S. Immunopotentiating compounds from

Tinospora cordifolia. J Ethnopharmacol 1997;58:89‑95.

Matthew S, Kuttan G. Immunomodulatory and antitumour

activities of Tinospora cordifolia. Fitoterapia 1999;70:35‑43.

Sharma PV, Chaturvedi C, Bandhopadhyaya NG. A study on

dosage and toxicity of Bhallataka (Semecarpus anacardium Linn.).

J Res Indian Med 1966; 1:130.

Premalatha B. Semecarpus anacardium Linn. nuts—a boon in

alternative medicine. Indian J Exp Biol 2000;38:1177‑82.

Cassady JM, Chang CJ, McLaughlin JL. Recent advances in the

isolation of structural elucidation of antineoplastic agents of

higher plants. In: Beal JL, Reinhard E, editors. Natural products

as medicinal agents. Verlag: Hippokrates; 1981. p. 93‑105.

Chitinis MP, Bhatia KG, Pathak MK, Kesava Rao KV. Antitumour

activity of the extract of Semecarpus anacardium L. nuts in

experimental tumour models. Indian J Exp Biol 1980;18:6‑8.

Premalatha B, Sachdanandam P. Immunomodulatory activity

of Semecarpus anacardium Linn. nut milk extract in Aflatoxin

B1 induced hepatocellular carcinoma in rats. Pharmacy and

Pharmacology Communications 1998;4:507‑10.

Premalatha B, Muthulakshmi V, Sachdanandam P. Anticancer

potency of the milk extract of Semecarpus anacardium Linn. nuts

against aflatoxin B1 mediated hepatocellular carcinoma bearing

Wistar rats with reference to tumour marker enzymes. Phytother

Res 1999;13:183‑7.

Premalatha B, Sachdanandam P. Effect of Semecarpus anacardium

nut milk extract on rat serum alpha‑fetoprotein level in aflatoxin

B1 mediated hepatocellular carcinoma. Fitoterapia 1999;70:279‑83.

Premalatha B, Sachdanandam P. Stabilization of lysosomal

membrane and cell membrane glycoprotein profile by Semecarpus

anacardium Linn. Nut milk extract in experimental hepatocellular

carcinoma. Phytother Res 2000;14:352‑5.

Premalatha B, Sachdanandam P. Regulation of mineral status by

Semecarpus anacardium Linn. Nut milk extract in aflatoxin B1

induced hepatocellular carcinoma. J Clin Biochem Nutr 1998;

:63‑70.

Premalatha B, Sujatha V, Sachdanandam P. Modulating effect of

Semecarpus anacardium Linn. Nut extract on glucose metabolizing

enzymes in aflatoxin B1 induced experimental hepatocellular

carcinoma. Pharmacol Res 1997;36:187‑92.

Premalatha B, Muthulakshmi V, Vijayalakshmi T, Sachdanandam

P. Semecarpus anacardium nut extract induced changes in

enzymic antioxidants studied in aflatoxin B1 caused hepatocellular

carcinoma bearing Wistar rats. Int J Pharmacog 1997;35:1‑6.

Premalatha B, Sachdanandam P. Semecarpus anacardium L nut

extract administration induces the in vivo antioxidant defense

system in aflatoxin B1 mediated hepatocellular carcinoma.

J Ethnopharmacol 1999;66:131‑9.

Premalatha B, Sachdanandam P. Potency of Semecarpus

anacardium Linn. nut milk extract against aflatoxin B1 induced

hepatocarcinogenesis: Reflection on microsomal biotransformation

enzymes. Pharmacol Res 2000;42:161‑6.

Premalatha B, Sachdanandam P. Modulating role of Semecarpus

anacardium L. Nut milk extract on aflatoxin B1 biotransformation.

Pharmacol Res 2000;41:19‑24.

Premalatha B, Sachdanandam P. Effect of Semecarpus anacardium

nut extract against aflatoxin B1 induced hepatocellular carcinoma.

Fitoterapia 1999;70:484‑92.

Vad BG. Study of complete regression in four cases of cancer.

Indian Pract 1973;26:253‑63.




DOI: https://doi.org/10.22377/ijgp.v6i2.244

Refbacks

  • There are currently no refbacks.